Tag: Personalized medicine

Cancer Cell Line Encyclopedia Expanded to Include RPPA Analysis Data

The Cancer Cell Line Encyclopedia is a collaborative project started in 2008 with the goal to characterize, from a genetic and pharmacological standpoint, a large panel of human cancer models. The idea was to develop data linking genetic profiles to pharmacological outcomes that can translate into personalized therapeutic regimens and accelerate cancer research. The dataset … Continued

Enabling Cell-based Assays and Translation to Personalized Medicine

Cell-based assays have expanded in use, and reduced in sample requirements over the past decade, driven by technologies that have improved the culture and monitoring of cell functions on a miniature scale. One of our partners, Microstem Inc., based in San Diego, CA, is an example of an early stage reagent development company that approached … Continued